Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Journal of Biochemical and Molecular Toxicology
|
February 11, 2017
The role of 5-HT<sub>2c</sub> receptor on corticosterone-mediated food intake
Tongtong Ge, Zhuo Zhang, Jiayin Lv, et al.
British Journal of Pharmacology
|
June 11, 2014
Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry
Kazumasu Sasaki, Akira Sumiyoshi, Hiroi Nonaka, et al.
Brain Research
|
November 15, 2011
A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period
Nobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Psychopharmacology
|
February 12, 2013
Impaired cliff avoidance reaction in dopamine transporter knockout mice
Motoyasu Yamashita, Yasufumi Sakakibara, F Scott Hall, et al.
Behavioural Pharmacology
|
February 22, 2014
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice
Nobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Brain Research Bulletin
|
June 3, 2025
Sodium-glucose cotransporter-2 inhibitor, dapagliflozin, reverses depressive-like behavior in a mouse model of post-traumatic stress disorder
Haneen Amawi, Tayma Makhlouf, Alaa M Hammad, et al.
Psychopharmacology
|
March 23, 2007
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice
Setsu Fukushima, Haowei Shen, Harumi Hata, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2013
Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice
Arihisa Ohara, Yoshiyuki Kasahara, Hideko Yamamoto, et al.
Journal of Pharmacological Sciences
|
February 24, 2023
Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
Yuki Moriya, Yoshiyuki Kasahara, Masafumi Shimada, et al.
Metabolic Brain Disease
|
May 20, 2025
Rhoifolin as a potential anxiolytic drug for the effects of nicotine withdrawal: beneficial effects on behavior, neuroinflammation, and oxidative stress
Alaa M Hammad, Suhair Sunoqrot, Thanaa Al-Zuhd, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Journal of Biochemical and Molecular Toxicology
|
February 11, 2017
The role of 5-HT<sub>2c</sub> receptor on corticosterone-mediated food intake
Tongtong Ge, Zhuo Zhang, Jiayin Lv, et al.
British Journal of Pharmacology
|
June 11, 2014
Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry
Kazumasu Sasaki, Akira Sumiyoshi, Hiroi Nonaka, et al.
Brain Research
|
November 15, 2011
A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period
Nobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Psychopharmacology
|
February 12, 2013
Impaired cliff avoidance reaction in dopamine transporter knockout mice
Motoyasu Yamashita, Yasufumi Sakakibara, F Scott Hall, et al.
Behavioural Pharmacology
|
February 22, 2014
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice
Nobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Brain Research Bulletin
|
June 3, 2025
Sodium-glucose cotransporter-2 inhibitor, dapagliflozin, reverses depressive-like behavior in a mouse model of post-traumatic stress disorder
Haneen Amawi, Tayma Makhlouf, Alaa M Hammad, et al.
Psychopharmacology
|
March 23, 2007
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice
Setsu Fukushima, Haowei Shen, Harumi Hata, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2013
Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice
Arihisa Ohara, Yoshiyuki Kasahara, Hideko Yamamoto, et al.
Journal of Pharmacological Sciences
|
February 24, 2023
Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
Yuki Moriya, Yoshiyuki Kasahara, Masafumi Shimada, et al.
Metabolic Brain Disease
|
May 20, 2025
Rhoifolin as a potential anxiolytic drug for the effects of nicotine withdrawal: beneficial effects on behavior, neuroinflammation, and oxidative stress
Alaa M Hammad, Suhair Sunoqrot, Thanaa Al-Zuhd, et al.
Page
of 11